James Biehl J.D.
Net Worth

Last updated:

What is James Biehl J.D. net worth?

The estimated net worth of Mr. James Biehl J.D. is at least $3,905,743 as of 15 Feb 2022. He owns shares worth $32,623 as insider and has received compensation worth at least $3,873,120 in Tyme Technologies, Inc..

What is the salary of James Biehl J.D.?

Mr. James Biehl J.D. salary is $645,520 per year as Chief Legal Officer & Sec. in Tyme Technologies, Inc..

How old is James Biehl J.D.?

Mr. James Biehl J.D. is 61 years old, born in 1964.

What stocks does James Biehl J.D. currently own?

As insider, Mr. James Biehl J.D. owns shares in one company:

Company Title Shares Price per share Total value
Tyme Technologies, Inc. (TYME) Chief Legal Officer & Sec. 105,000 $0.31 $32,623

What does Tyme Technologies, Inc. do?

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. As of September 16, 2022, Tyme Technologies, Inc. operates as a subsidiary of Syros Pharmaceuticals, Inc.

TYME logo
TYME
Tyme Technologies, Inc.
$0.31

James Biehl J.D. insider trading

Tyme Technologies, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 20,000 $0.34 $6,800
Purchase
Common Stock 10,000 $0.65 $6,500
Purchase
Common Stock 10,000 $0.95 $9,500
Purchase
Common Stock 10,000 $0.95 $9,500
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 15,000 N/A N/A

Tyme Technologies key executives

Tyme Technologies, Inc. executives and other stock owners filed with the SEC: